RecallDepth
Class II Terminated

Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (when mixed) bottles (NDC 68180-402-02); and c) 100 mL (when mixed) bottles (NDC 68180-402-03); Rx only, Manufactured for: Lupin Pharmaceutical, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Mandideep 462 046, India.

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
March 26, 2021
Posted
April 21, 2021
Recall Number
D-0332-2021
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 6,816 bottles; b) 3,960 bottles and c) 7,038 bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

Superpotent Drug

Distribution

Nationwide in the USA and Puerto Rico

Lot / Code Info

Lot Numbers: a) F801122, exp. date June 2021; b) F801123, exp. date June 2021; c) F801124, exp. date June 2021

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls